Source

OMDIFY

Swiss trademark · 754031 · Word mark · In force

Register entry

Registration number
754031
Application number
15092/2020
Status
In force
Type
Word mark
Filed
Oct 26, 2020
Registered
Oct 26, 2020
Published
Oct 26, 2020
Protected until
Oct 26, 2030
Language of procedure
German

Goods and services

Pharmaceuticals

Pharmazeutische Präparate und Substanzen zur Behandlung von viralen, metabolischen, endokrinen, muskuloskelettalen, kardiovaskulären, kardiopulmonalen, urogenitalen, onkologischen, hepatologischen, ophthalmischen, respiratorischen, neurologischen, gastrointestinalen, hormonellen, dermatologischen, psychiatrischen und das Immunsystem sowie sexuelle Dysfunktion betreffenden Erkrankungen und Störungen.

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 31, 2024

    Agent’s address changed

    Representative
    Baker McKenzie Zurich, Holbeinstrasse 30, 8034 Zürich → Baker McKenzie Switzerland AG, Holbeinstrasse 30, 8034 Zürich

    Published in Swissreg on 31.01.2024

  2. Oct 26, 2020

    Registered

    Published in Swissreg on 26.10.2020

Parties

Holder

Abbvie Inc.

AbbVie Inc

1 North Waukegan Road, 60064 North Chicago, Illinois, US

Agent

Baker McKenzie Switzerland AG

Holbeinstrasse 30, 8034 Zürich

The register names each party by name and address. A party is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.